HC Wainwright & Co. reiterated coverage on electroCore with a new price target
$ECOR
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Health Care
HC Wainwright & Co. reiterated coverage of electroCore with a rating of Buy and set a new price target of $2.75 from $3.00 previously